CalciMedica Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:CalciMedica Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10878
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CalciMedica Inc (CalciMedica) is a pharmaceutical company that develops small molecule drugs for the treatment of acute and chronic inflammatory and autoimmune disorders and organ transplant rejection. The company’s CM2489 is a compound developed to treat moderate plaque psoriasis. It also identifies CRAC channel inhibitors that are used in animal models of immune disease. The company develops products for the treatment of Alzheimer’s disease and autoimmune diseases including rheumatoid arthritis, psoriasis, lupus, acute pancreatitis, Crohn’s disease and type I diabetes, among others. CalciMedica is headquartered in La Jolla, California, the US.

CalciMedica Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CalciMedica Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Calcimedica Raises Us$2.5 Million In Venture Financing 10
CalciMedica Raises US$3 Million In Venture Financing 11
CalciMedica Raises US$4.6 Million In Venture Financing 12
CalciMedica Raises US$13.2 Million In Venture Financing 13
CalciMedica Inc – Key Competitors 14
CalciMedica Inc – Key Employees 15
CalciMedica Inc – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Product Approvals 17
May 24, 2017: CalciMedica Receives Fast-Track Designation for CM4620, a Novel CRAC Channel Inhibitor to Treat Acute Pancreatitis 17
Clinical Trials 18
Jan 05, 2017: CalciMedica Initiates Phase 1 Clinical Studies for CRAC Channel Inhibitor 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
CalciMedica Inc, Pharmaceuticals & Healthcare, Key Facts 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Calcimedica Raises Us$2.5 Million In Venture Financing 10
CalciMedica Raises US$3 Million In Venture Financing 11
CalciMedica Raises US$4.6 Million In Venture Financing 12
CalciMedica Raises US$13.2 Million In Venture Financing 13
CalciMedica Inc, Key Competitors 14
CalciMedica Inc, Key Employees 15

List of Figures
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CalciMedica Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[CalciMedica Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • BELLUS Health, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BELLUS Health, Inc. Mergers and …
  • Ta Chen Stainless Pipe Co. Ltd.:企業の戦略・SWOT・財務分析
    SummaryTa Chen Stainless Pipe Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the comp …
  • Salt River Project Agricultural Improvement And Power District(エネルギー分野):企業M&A動向
    Summary Salt River Project Agricultural Improvement and Power District (SRP) is an integrated power utility. The company offers electricity to a range of residential and commercial customers in Arizona, the US. It is an integrated utility providing generation, transmission and distribution services. …
  • BBVA Banco Frances S.A.:企業の戦略・SWOT・財務分析
    BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report Summary BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Koninklijke Philips N.V.:企業の戦略・SWOT・財務分析
    SummaryKoninklijke Philips N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Ke …
  • Shaw Media Inc.:企業概要及び戦略的SWOT分析
    Shaw Media Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Galectin Therapeutics, Inc. (GALT):企業概要、財務及び戦略的SWOT分析
    Summary Galectin Therapeutics, Inc. (Galectin Therapeutics) is a biotechnology company. The company discovers, develops and commercializes therapies for fibrotic disease and cancer. Its products include GR-MD-02 and GM-CT-01. The company’s GR-MD-02 is a drug candidate used in the treatment of fibrot …
  • Carrefour SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Carrefour SA Mergers and Acquis …
  • Chugoku Marine Paints, Ltd. (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints, Ltd. (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • TOWER Limited (TWR):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "TOWER Limited" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly follows a s …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Greatbatch, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Greatbatch, Inc. Mergers and Ac …
  • OncoResponse Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OncoResponse Inc (OncoResponse) focuses on the discovery, development and commercialization of therapeutic antibodies for the treatment of cancer. The company’s lead program includes ONCR-201, an anti-EMP2 fully-human monoclonal antibody, which is developed for female malignancies. It utiliz …
  • PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research …
  • Moravske naftove doly AS:企業の戦略的SWOT分析
    Moravske naftove doly AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Medrad, Inc.:(医療機器分野)企業M&A及び提携動向
    Summary Medrad, Inc. (Medrad) is a medical device company. The company develops and markets medical devices that are used to diagnose and treat diseases. Its products include CT informatics platform, CT injection systems, MRI injection systems, MRI monitoring, CT injector accessories, molecular imag …
  • Luna Innovations Inc (LUNA):企業のM&A・提携動向(医療機器分野)
    Summary Luna Innovations Inc (Luna) is a technology development company that research, develops and commercializes speed optics and fiber optic test products. The company’s products include fiber optic sensing products, fiber optic test and measurement products, high speed optical products, terahert …
  • JO Group Holdings Co., Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' JO Group Holdings Co., Ltd. Mer …
  • Nanosphere Inc-製薬・医療分野:企業M&A・提携分析
    Summary Nanosphere Inc (Nanosphere) a subsidiary of Cepheid is a medical device company that develops molecular diagnostic tests for disease detection and patient treatment. The company’s products comprise verigene system, instrumentation, bloodstream infection tests, gastrointestinal infection test …
  • BG Medicine, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BG Medicine, Inc. Mergers and A …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆